Spero Therapeutics SPRO Slips 241 as Stock Tests Key Support at 269 Snapon Stock Wall Street Analysts Weigh In on Price Targets WIMI Q4 2020 Earnings EPS Misses Estimates as Stock Declines Proposed 250 Trump Note Sparks Debate on US Currency Policy